Saving Time, Money and Lives Through Rapid Plug & Play Salmonella Diagnostics

Projektinformationen

DART Diagnostics

ID Finanzhilfevereinbarung: 827023

DOI 10.3030/827023

Abgeschlossenes Projekt

EK-Unterschriftsdatum 7 August 2018

Startdatum 1 September 2018

Enddatum 28 Februar 2019

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten € 71 429,00

EU-Beitrag € 50 000,00

Koordiniert durch

ABDART DIAGNOSTICS LDA
Portugal

Ziel

Salmonella is the major food poisoning agent but it takes 3-5 days to detect Salmonella with current state-of-the-art testing technologies. But since food manufacturers need to send out products to retailers before that, the pathogen might already have spread before it gets detected.
DART is a new technology that allows immunoassays to have improved sensitivity in general. Its most pressing application is for the detection of Salmonella. DART is a fast detection kit of the Salmonella bacteria for food safety applications, based on a unique amplification reagent originally developed by us and enabled by the latest nano-medical advances.
Our unique approach is based on bringing the benefits of one of the latest discoveries in nanomedicine to industrial pathogen diagnostics. We created our startup company, ABDART Diagnostics Lda., with the purpose of improving diagnostics. We have received an investment from Caixa Capital who invested €100,000 to help use get to TRL6.
Our target market is the European Food Safety market sized at around €4 billion in 2018. Applying the global 20% share of Salmonella kits, this is around €800 million.
To get to commercialization, we need to decide on a specific roadmap (Phase I Project). Then, we need to enter the commercial product development and testing phase (Phase II Project). We will sell Dart kits to our market right after the Phase 2 project when we have all the necessary validations and certifications. We plan to charge €15 per kit, which is in line with prices of DNA-based tests and slightly higher than immunoassay-based competitors, both of which take much longer to have the test results (days) than via our approach (hours).
We can help reverse the main issue in Europe, which is that Salmonella outbreaks are not falling despite the resources and funding the EC is investing. A wide uptake of DART can result in Salmonella outbreaks to fall again.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › microbiology › bacteriology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › medical biotechnology › nanomedicine
• engineering and technology › other engineering and technologies › food technology › food safety
• engineering and technology › nanotechnology › nano-materials

Programm/Programme

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Thema/Themen

• EIC-SMEInst-2018-2020 - SME instrument

Aufforderung zur Vorschlagseinreichung

H2020-EIC-SMEInst-2018-2020

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEInst-2018-2020-1

Finanzierungsplan

SME-1 - SME instrument phase 1

Koordinator

ABDART DIAGNOSTICS LDA

• Netto-EU-Beitrag: € 50 000,00
• Adresse: TEC LABS - CENTRO DE INOVACAO CAMPUS DA FCUL SN CAMPO GRANDE ; 1749 016 LISBOA ; Portugal
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Continente › Área Metropolitana de Lisboa › Área Metropolitana de Lisboa
• Region: Continente › Área Metropolitana de Lisboa › Área Metropolitana de Lisboa
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 71 429,00